Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04228367 · ClinicalTrials.gov registry record · NA
JuggerStitch Post Market Clinical Follow-up Study
A NA study of Meniscus Tear, Tibial and Meniscus Lesion, sponsored by Zimmer Biomet.
- Recruiting
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 6
- Study locations
NCT04228367: Recruiting NA study of Meniscus Tear, Tibial and Meniscus Lesion, sponsored by Zimmer Biomet.
NCT04228367 is a NA study of Meniscus Tear, Tibial and Meniscus Lesion that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 104 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04228367, a NA study of Meniscus Tear, Tibial and Meniscus Lesion, is actively recruiting participants, sponsored by Zimmer Biomet.
- RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 6
- Study locations
Study Summary
This study is a post-market follow-up study. The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (Instruction For Use).
Primary Outcome
The absence of reoperation due to meniscal tear. This will be measured against the success criteria of the absence of reoperation in 90.2% of the cases at one year.
Conditions Studied
Interventions
- DEVICE JuggerStitch Meniscal Repair Device
Study Locations (6)
Other
- Ramsay General de Sante - Hôpital Privé Jean Mermoz - Centre Orthopédique Santy - Lyon
- Medizinische Fakultät der Otto-von-Guericke-Universität Magdeburg - Magdeburg
- Tokyo Medical and Dental University Hospital of Medicine - Tokyo
North Carolina
- OrthoCarolina - Charlotte
Virginia
- OrthoVirginia, Inc. - Richmond
Ibaraki
- Ichihara Hospital - Tsukuba
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2020-09-25 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT04228367 shows while recruiting
NCT04228367 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Meniscus Tear, Tibial appearing as the primary indexed condition, and to 1 intervention - of which JuggerStitch Meniscal Repair Device is the first listed.
NCT04228367 lists 6 locations in 4 states (Other, North Carolina, Virginia).
Frequently Asked Questions
What is clinical trial NCT04228367 about?
NCT04228367 is a clinical study titled "JuggerStitch Post Market Clinical Follow-up Study". This study is a post-market follow-up study. The data collected from this study will serve the purpose of confirming the safety and performance of the JuggerStitch Device used for meniscal repair according to the product labelling (Instruction For Use).
What is the current status of trial NCT04228367?
This trial is currently recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2020-09-25. Estimated completion is 2026-04-30.
What conditions does trial NCT04228367 study?
This clinical trial studies the following conditions: Meniscus Tear, Tibial, Meniscus Lesion.
What interventions are being tested in trial NCT04228367?
The interventions under investigation include: JuggerStitch Meniscal Repair Device (DEVICE).
Who is sponsoring clinical trial NCT04228367?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04228367 being conducted?
This trial has 6 study locations across North Carolina, Virginia, Ibaraki. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meniscus Tear, Tibial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04228367's enrollment target sits among peer trials
104 836th of 2000 higher than 1,164 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
- NCT05064280 · 104 participants · Phase 2
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI